Segment Information

6 Months Ended

Jun. 30, 2021

Segment Reporting [Abstract]

Segment Information

Note 14 – Segment Information

The Company has identified two operating segments, diagnostic services and consumer products, based on the manner in which the Company’s CEO as CODM assesses performance and allocates resources across the organization. The operating segments are organized in a manner that depicts the difference in revenue generating synergies that include the separate processes, profit generation and growth of each segment. The diagnostic services segment provides COVID-19 diagnostic information services to a broad range of customers in the United States, including health plans, third party payers and government organizations. The consumer products segment is engaged in the research, development, manufacture, distribution, marketing and sale of OTC consumer healthcare products and dietary supplements in the United States. The unallocated corporate expenses mainly included professional fees associated with the public company.

The following table is a summary of segment information for three and six months ended June 30, 2021 and 2020 (amounts in thousands):

	For the three months ended						For the six months ended
	June 30, 2021			June 30, 2020			June 30, 2021			June 30, 2020
Net revenues
Diagnostic services	$	7,537		$	-		$	20,274		$	-
Consumer products		1,605			3,623			4,139			5,511
Consolidated net revenue		9,142			3,623			24,413			5,511
Cost of revenue
Diagnostic services		3,479			-			7,824			-
Consumer products		1,197			2,344			3,196			3,817
Consolidated cost of revenue		4,676			2,344			11,020			3,817
Depreciation and amortization expense
Diagnostic services		392			-			737			-
Consumer products		3			5			6			10
Total Depreciation and amortization expense		395			5			743			10
Operating and other expenses		5,466			1,204			12,988			2,423
Income (loss) from continuing operations, before income taxes
Diagnostic services		1,164			-			4,004			-
Consumer products		540			1,274			505			1,684
Unallocated corporate		(3,099	)		(1,204	)		(4,847	)		(2,423	)
Total income (loss) from continuing operations, before income taxes		(1,395	)		70			(338	)		(739	)
Net income (loss)	$	(1,395	)	$	70		$	(338	)	$	(739	)

The following table is a summary of segment balance sheets information as of June 30, 2021 and December 31, 2020 (in thousands):

	June 30,		December 31,
	2021		2020
ASSETS
Diagnostic services	$	32,222	$	13,410
Consumer products		5,294		6,261
Unallocated corporate		38,807		11,734
Total assets	$	76,323	$	31,405